Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia

• Published in: International journal of clinical practice (Esher) Vol. 60; no. 3; p. 308
• Main Authors: Wright, Jr, E, Scism-Bacon, J L, Glass, L C
• Format: Journal Article
• Language: English
• Published: England 01-03-2006
• Subjects: Adult; Aged; Atherosclerosis - diagnosis; Biomarkers - metabolism; Blood Glucose - metabolism; Diabetes Mellitus, Type 2 - diagnosis; Diabetes Mellitus, Type 2 - drug therapy; Diabetes Mellitus, Type 2 - metabolism; Diabetic Angiopathies - diagnosis; Early Diagnosis; Fasting - physiology; Glycated Hemoglobin A - metabolism; Humans; Hyperglycemia - prevention & control; Hypoglycemic Agents - therapeutic use; Lipids - blood; Middle Aged; Nitric Oxide - metabolism; Oxidative Stress - physiology; Postprandial Period - physiology
• ISSN: 1368-5031
• DOI: 10.1111/j.1368-5031.2006.00825.x

Oxidative stress, through the production of reactive oxygen species (ROS), has been proposed as the root cause underlying the development of insulin resistance, beta-cell dysfunction, impaired glucose tolerance and type 2 diabetes mellitus (T2DM). It has also been implicated in the progression of long-term diabetes complications, including microvascular and macrovascular dysfunction. Excess nourishment and a sedentary lifestyle leads to glucose and fatty acid overload, resulting in production of ROS. Additionally, reaction of glucose with plasma proteins forms advanced glycation end products, triggering production of ROS. These ROS initiate a chain reaction leading to reduced nitric oxide availability, increased markers of inflammation and chemical modification of lipoproteins, all of which may increase the risk of atherogenesis. With the postulation that hyperglycaemia and fluctuations in blood glucose lead to generation of ROS, it follows that aggressive treatment of fasting and postprandial hyperglycaemia is important for prevention of micro and macrovascular complications in T2DM.